BOUNCE

[dav1234]

Home health providers are in for a rough session after Baird downgrades the entire sector to sell and slashes price targets. Noting the stocks have moved up in anticipation of the best outcome for the Medicare update, Baird says the actual result - including the rebase - couldn't have been worse. "Importantly, CMS's methodology ties its hands and leaves very little hope for a large reprieve in the final rule." AMED -12.8%, GTIV -11.7%, AFAM -9.5%, LHCG -5.9% premarket.